Immune Activation Could Hold the Key to Success of Dual-Target CAR T Therapy in Glioblastoma
Recurrent glioblastoma (GBM), a notoriously aggressive and lethal brain cancer, continues to pose a formidable challenge for oncology, partly due...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Recurrent glioblastoma (GBM), a notoriously aggressive and lethal brain cancer, continues to pose a formidable challenge for oncology, partly due...
In a groundbreaking phase 3 international clinical trial, researchers have unveiled a promising new immunotherapy combination that could redefine the...
In a groundbreaking advancement spearheaded by scientists at the University of Maryland School of Medicine, new insights into CAR T-cell...
SCOTTSDALE, Ariz. — On June 9, 2026, the HonorHealth Research Institute marked a pivotal evolution in its research infrastructure with...
In a groundbreaking preclinical study, researchers at Weill Cornell Medicine and the Cornell Duffield College of Engineering have unveiled a...
Los Angeles, CA – June 15, 2026 – In a groundbreaking development for brain cancer research, a consortium of leading...
In an era where personalized medicine and patient-centered care are becoming paramount, a groundbreaking study published in the June 2026...
In a groundbreaking study poised to reshape pediatric oncology care in low- and middle-income countries (LMICs), researchers have unveiled compelling...
In a groundbreaking synthesis of global research, a systematic review and meta-analysis led by Watts, E.L., Gonzalez-Feliciano, A., Gunter, M.J.,...
In an era where the global prevalence of obesity continues its relentless march, the intricate relationship between excess adiposity and...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine